Evolution of strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in France

• Main Authors: Eva Hong (Author), Aude Terrade (Author), Alessandro Muzzi (Author), Rosita De Paola (Author), Giuseppe Boccadifuoco (Author), Rita La Gaetana (Author), Ala-Eddine Deghmane (Author), Mariagrazia Pizza (Author), Laura Serino (Author), Muhamed-Kheir Taha (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The 4CMenB, a protein-based vaccine, was licensed in Europe in 2013 against invasive meningococcal disease caused by serogroup B and is currently implemented in several countries although according to different national strategies. Isolate coverage estimation is required as vaccine-targeted antigens...